Acute Myeloid Leukemia | Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Acute Myeloid Leukemia

Proceedings from part 3 of a 4-part webinar series during the 62nd ASH Annual Meeting. Featuring perspectives from Drs Mark Levis, Alexander Perl, Daniel A Pollyea, Eytan M Stein and Andrew H Wei on the following topics: Introduction (0:00) Optimizing the Management of AML in Older Patients or Those Ineligible for Intensive Chemotherapy (1:00) Treatment Options for Patients with AML Harboring FLT3 Mutations (18:43) Management of Newly Diagnosed and Previously Treated AML with IDH Mutations (39:38) Tailoring Induction and Maintenance Therapy for Younger Patients with AML without Targetable Tumor Mutations (55:33) Other Novel Agents and Investigational Strategies for Patients with AML (1:12:38) CME information and select publications